UnitedHealth Group Incorporated (NYSE:UNH) is Intech Investment Management LLC’s 9th Largest Position

Intech Investment Management LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 41.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 197,914 shares of the healthcare conglomerate’s stock after selling 139,340 shares during the quarter. UnitedHealth Group makes up approximately 1.3% of Intech Investment Management LLC’s holdings, making the stock its 9th largest holding. Intech Investment Management LLC’s holdings in UnitedHealth Group were worth $115,716,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. King Luther Capital Management Corp increased its position in UnitedHealth Group by 8.1% during the 3rd quarter. King Luther Capital Management Corp now owns 193,605 shares of the healthcare conglomerate’s stock worth $113,197,000 after purchasing an additional 14,537 shares in the last quarter. Cornerstone Advisors LLC boosted its stake in UnitedHealth Group by 5.2% in the 3rd quarter. Cornerstone Advisors LLC now owns 50,403 shares of the healthcare conglomerate’s stock worth $29,470,000 after buying an additional 2,500 shares during the last quarter. Citizens Financial Group Inc. RI boosted its stake in UnitedHealth Group by 6.4% in the 3rd quarter. Citizens Financial Group Inc. RI now owns 43,036 shares of the healthcare conglomerate’s stock worth $25,162,000 after buying an additional 2,600 shares during the last quarter. EverSource Wealth Advisors LLC boosted its stake in UnitedHealth Group by 10.1% in the 3rd quarter. EverSource Wealth Advisors LLC now owns 2,887 shares of the healthcare conglomerate’s stock worth $1,688,000 after buying an additional 265 shares during the last quarter. Finally, Altman Advisors Inc. acquired a new stake in UnitedHealth Group in the 3rd quarter worth about $1,787,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

A number of analysts have issued reports on UNH shares. Barclays decreased their price target on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 22nd. Morgan Stanley reduced their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. Hsbc Global Res lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. Royal Bank of Canada reduced their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 16th. Finally, UBS Group reduced their price objective on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $600.50 on Thursday. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $552.63 billion, a price-to-earnings ratio of 39.12, a price-to-earnings-growth ratio of 1.69 and a beta of 0.58. The business has a 50 day simple moving average of $582.52 and a 200-day simple moving average of $551.60.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same period in the previous year, the business earned $6.56 EPS. The business’s quarterly revenue was up 9.2% on a year-over-year basis. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be given a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.40%. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.